Ronald Korn Net Worth

The estimated Net Worth of Ronald J Korn is at least $2.35 Million dollars as of 13 January 2021. Mr. Korn owns over 2,000 units of Petmed Express stock worth over $282,499 and over the last 21 years he sold PETS stock worth over $1,912,120. In addition, he makes $159,850 as Independent Director at Petmed Express.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Korn PETS stock SEC Form 4 insiders trading

Ronald has made over 34 trades of the Petmed Express stock since 2008, according to the Form 4 filled with the SEC. Most recently he sold 2,000 units of PETS stock worth $70,000 on 13 January 2021.

The largest trade he's ever made was selling 5,000 units of Petmed Express stock on 29 January 2018 worth over $241,900. On average, Ronald trades about 802 units every 45 days since 2003. As of 13 January 2021 he still owns at least 83,333 units of Petmed Express stock.

You can see the complete history of Mr. Korn stock trades at the bottom of the page.

Ronald Korn biography

Ronald J. Korn J.D. serves as Independent Director of the Company. Since 1991, Mr. Korn has served on the Board of Directors and as Audit Committee Chair for a number of public companies. From 1961 to 1991, he was a partner and employee of KPMG, LLP, an international accounting firm, where his client responsibilities included a number of large financial institutions and various public corporations. In addition to serving on the Company’s Board, Mr. Korn served as a Director and a member of the Audit Committee of Ocwen Financial Corporation (NYSE:OCN) from July 2003 until his retirement from that Board in May 2017. He was also the Audit Committee Chairman from July 2003 until May 2015. From November 2005 until his retirement in September 2017, he also served as a Director on the Board, and member of the Audit Committee of comScore, Inc., formerly ComScore Networks, Inc. and except for a short period of time, as Chairman of the Audit Committee. Mr. Korn previously served as a Director and Chairman of the Audit Committee of a number of public companies and a privately held financial institution. Mr. Korn currently holds inactive licenses as a Certified Public Accountant in New York, Michigan, and Florida. Mr. Korn also holds a Juris Doctor degree from the New York University Law School and a Bachelor of Science degree in Economics from the University of Pennsylvania, Wharton School. Mr. Korn’s extensive and high-level experience in the financial services industry as well as his board involvement with numerous other businesses and organizations enables Mr. Korn to make very significant contributions to the Board’s decision-making processes especially in financial matters. The depth and breadth of Mr. Korn’s experience and skills are also evident by the fact that he qualifies as an audit committee financial expert and serves as Chair of our Audit Committee.

What is the salary of Ronald Korn?

As the Independent Director of Petmed Express, the total compensation of Ronald Korn at Petmed Express is $159,850. There are 4 executives at Petmed Express getting paid more, with Menderes Akdag having the highest compensation of $1,303,460.

How old is Ronald Korn?

Ronald Korn is 80, he's been the Independent Director of Petmed Express since 2002. There are no older and 8 younger executives at Petmed Express.

Insiders trading at Petmed Express

Over the last 24 years, insiders at Petmed Express have traded over $24,134,502 worth of Petmed Express stock and bought 61,738 units worth $451,498 . The most active insiders traders include Gian Fulgoni, Menderes Akdag, and Robert C Schweitzer. On average, Petmed Express executives and independent directors trade stock every 36 days with the average trade being worth of $26,079. The most recent stock trade was executed by Jacqueline Paula Smith on 15 August 2024, trading 601 units of PETS stock currently worth $1,917.

What does Petmed Express do?

petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.

Complete history of Mr. Korn stock trades at Petmed Express, Ocwen, and Comscore

Petmed Express executives and stock owners

Petmed Express executives and other stock owners filed with the SEC include:

• Menderes Akdag,
  President, Chief Executive Officer, Director
• Bruce Rosenbloom,
  Chief Financial Officer, Treasurer
• Bruce S. Rosenbloom,
  CFO & Treasurer
• Robert Schweitzer,
  Independent Chairman of the Board
• Ronald Korn,
  Independent Director
• Gian Fulgoni,
  Independent Director
• Frank Formica,
  Independent Director
• Leslie Campbell,
  Independent Director
• Matthew N. Hulett,
  CEO, Pres & Director
• Wendy Zalai,
  Corp. Controller & Corp. Sec.
• Diana G Purcel,
  Director
• Peter Cobb,
  Director
• Jodi Watson,
  Director
• Guren Kivilcim,
  Director
• Marc Mdmarpul Investments L...,
  
• Holdings Llc Tricon,
  10% owner
• Marc Md Puleo,
  President/Chairman of Board
• Ltd Creslin,
  10% owner
• Marc Mdmarpul Trust / South...,
  
• Leah Solivan,
  Director
• Jacqueline Paula Smith,
  
• Daniel Job Pingree,
  
• Mark Bradley Jr Moseley,
  
• Christine Chambers,
  CFO
• Mathew N Hulett,
  
• Sandra Yvette Campos,
  CEO & President
• Justin L. Mennen,
  Director